0By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as…
Read MoreGalaxy phones and tablets finally receive a paramount software update after many months of waiting in vain – PhoneArena
Galaxy phones and tablets finally receive a paramount software update after many months of waiting in vain PhoneArenasource
Read MorePolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀ – Yahoo Finance
PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀ Yahoo Financesource
Read MoreNew surgical infection drug from PolyPid heads to FDA decision in 2027 – Stock Titan
Datavault AI Signs $2.0 Billion Structured Financing Term Sheet W…Robo.ai Announces Completion of 100% Acquisition of Neurovia AI, …Sphere 3D…
Read MoreRevolut Cracks India with 450K Waitlist Ahead of Full Launch – The Tech Buzz
Your premier source for technology news, insights, and analysis. Covering the latest in AI, startups, cybersecurity, and innovation.Get the latest…
Read MoreIndia tech hiring falls to 28 month low as demand drops 17 per cent – Indian Television Dot Com
Active openings slide to 93,000 amid global uncertainty and weaker IT demandPublishedonByMUMBAI: The hiring engine seems to have hit a…
Read MoreRaptee.HV becomes first EV motorcycle OEM to secure TDB funding – ET Auto
News See whats happening in Automobile Industry right now Exclusive Breaking, In-depth & Industry Inside Stories Leaders Speak Business leaders…
Read MoreI'm Calling A Bottom For Software—3 Stocks I'm Buying – Seeking Alpha
narvo vexar/iStock via Getty Images narvo vexar/iStock via Getty ImagesAfter a brutal start to 2026, the software complex is finally…
Read MoreRaptee.HV Secures Funding from Government's Technology Development Board – scanx.trade
source
Read MoreOutlook Therapeutics Announces Resubmission of Biologics License Application to U.S. FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg) – Yahoo Finance Singapore
Something went wrongISELIN, N.J., June 01, 2026 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on…
Read More
